Patents by Inventor Philippe Glaser

Philippe Glaser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rapid detection of the “high virulent” ST-17 clone of group B
    Patent number: 9874560
    Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: January 23, 2018
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
    Inventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Sauvage, Philippe Glaser, Patrick Trieu-Cuot
  • RAPID DETECTION OF THE "HIGH VIRULENT" ST-17 CLONE OF GROUP B STREPTOCOCCUS
    Publication number: 20170052181
    Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.
    Type: Application
    Filed: October 12, 2016
    Publication date: February 23, 2017
    Applicants: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
    Inventors: Claire POYART, Marie-Cecile LAMY, Shaynoor DRAMSI, Elisabeth SAUVAGE, Philippe GLASER, Patrick TRIEU-CUOT
  • Rapid detection of the “high virulent” ST-17 clone of group B
    Patent number: 9551039
    Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: January 24, 2017
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
    Inventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Sauvage, Philippe Glaser, Patrick Trieu-Cuot
  • RAPID DETECTION OF THE "HIGH VIRULENT" ST-17 CLONE OF GROUP B STREPTOCOCCUS
    Publication number: 20140302498
    Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.
    Type: Application
    Filed: April 16, 2014
    Publication date: October 9, 2014
    Applicants: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
    Inventors: Claire POYART, Marie-Cecile LAMY, Shaynoor DRAMSI, Elisabeth SAUVAGE, Philippe GLASER, Patrick TRIEU-CUOT
  • Rapid detection of the “high-virulent” ST-17 clone of group B
    Patent number: 8735565
    Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by the polynucleotides, as well as to antibodies directed or raised against the polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: May 27, 2014
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique, Universite Paris Descartes, Assistance Publique-Hospitaux de Paris
    Inventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Couve, Philippe Glaser, Patrick Trieu-Cuot
  • RAPID DETECTION OF THE "HIGH-VIRULENT" ST-17 CLONE OF GROUP B STREPTOCOCCUS
    Publication number: 20090162847
    Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.
    Type: Application
    Filed: December 20, 2006
    Publication date: June 25, 2009
    Applicants: INSTITUT PASTEUR, UNIVERSITE RENE DESCARTES (PARIS V), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Couve, Philippe Glaser, Patrick Trieu-Cuot
  • Sequence of the photorhabdus luminescens strain tt01 genome and uses
    Publication number: 20070020625
    Abstract: The present invention relates to the genomic sequence and to nucleotide sequences encoding polypeptides of Photorhabdus luminescens. The present invention further relates to polypeptides involved in operons involved in the biosynthesis of antibiotics or toxins, as well as polypeptides with activity of the antibiotic or toxin. Uses of the aforementioned polypeptides in pesticides, bactericides, or fungicides is provides. In addition, the present invention provides vectors, cells, or animals containing the sequences of the present invention.
    Type: Application
    Filed: February 7, 2002
    Publication date: January 25, 2007
    Inventors: Eric Duchaud, Sead Taourit, Philippe Glaser, Lionel Frangeul, Frederik Kunst, Antoine Danchin, Carmen Buchrieser
  • Molecular typing of listeria monocytogenes, hybridization supports and kits for said molecular typing
    Publication number: 20060257894
    Abstract: This invention provides 163 genes that are unique to the L. monocytogenes serovar 4b strain, CLIP80459, compared with L. monocytogenes EGDe strain. These genes are the basis for isolated nucleic acids, hybridization supports, and kits comprising a nucleotide sequence that is unique to a serovar 4b strain of L. monocytogenes. The invention also provides methods for identifying a L. monocytogenes in a sample, methods for identifying the lineage of a L. monocytogenes in a sample, and methods for sub-lineage typing of a L. monocytogenes in a sample. The invention also provides hybridization supports comprising a L. monocytogenes lineage-specific nucleic acid sequence, hybridization supports comprising a L. monocytogenes sub-lineage-specific nucleic acid sequence combination, and kits comprising a nucleic acid or hybridization support of the invention. Additionally, the invention provides specific macroarrays, methods, and kits for use in serotyping L. monocytogenes.
    Type: Application
    Filed: February 21, 2006
    Publication date: November 16, 2006
    Inventors: Michel Doumith, Carmen Buchrieser, Philippe Glaser, Paul Martin, Christine Jacquet, Patricia Garrido, Christophe Rusniok, Frederik Kunst
  • Listeria monocytogenes genome, polypeptides and uses
    Publication number: 20060078901
    Abstract: The genome sequence and nucleotide sequences of Listeria monocytogenes EGD-e are provided. Polypeptide sequences, including surface or cell envelope polypeptides, and polypeptides involved in metabolism, including B12 biosynthesis, are also provided. Uses of these sequences are also provided.
    Type: Application
    Filed: January 28, 2005
    Publication date: April 13, 2006
    Inventors: Carmen Buchrieser, Lionel Frangeul, Elisabeth Couve, Christophe Rusniok, Hafida Fsihi, Pierre Dehoux, Olivier Dussurget, Farid Chetouani, Hafed Nedjari, Philippe Glaser, Franck Kunst, Pascale Cossart, Justin Daniels, Werner Goebei, Jurgen Kreft, Michael Kuhn, Eva Ng, Jose Vazquez-Boland, Gustavo Dominguez-Bernal, Patricia Garrido-Garcia, Alberto Tierrez-Martinez, Alexandra Amend, Trinad Chakraborty, Eugen Domann, Thorsten Hain, Patrick Berche, Alain Charbit, Lionel Durant, Jose-Claudio Perez-Diaz, Fernando Baquero, Francisco Garcia Del Portillo, Nuria Gomez-Lopez, Encarna Maduenio, Betriz de Pablos, Jurgen Wehland, Uwe Karst, Karl-Dieter Entian, Jorg Hauf, Matthias Rose, Hamut Voss
  • Listeria inocua, genome and applications
    Publication number: 20040018514
    Abstract: The invention concerns a nucleotide sequence derived from Listeria inocua corresponding to a sequence selected among SEQ ID NO: 1 to SEQ ID NO: 11 and the comparative analysis of said genome with that of Listeria monocytogenes.
    Type: Application
    Filed: July 10, 2003
    Publication date: January 29, 2004
    Inventors: Frederik Kunst, Philippe Glaser
  • Adenyl cyclase derivatives and their biological uses
    Patent number: 5183745
    Abstract: The adenyl cyclase derivatives are atoxic derivatives in which one or several amino acids are different from those present in the toxic protein, the antibodies formed against these derivatives recognize, however, the toxic protein. These derivatives can be used as vaccines.
    Type: Grant
    Filed: October 25, 1989
    Date of Patent: February 2, 1993
    Assignee: Institut Pasteur
    Inventors: Antoine Danchin, Philippe Glaser, Evelyne Krin, Octavien Barzu, Daniel Ladant, Agnes Ullmann